HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Indomethacin protects rats from neuronal damage induced by traumatic brain injury and suppresses hippocampal IL-1β release through the inhibition of Nogo-A expression.

AbstractBACKGROUND:
Nogo-A is a member of the reticulon family of membrane-associated proteins and plays an important role in axonal remodeling. The present study aimed to investigate alterations in Nogo-A expression following traumatic brain injury (TBI)-induced inflammation and neuronal damage.
METHODS:
A weight-drop device was used to deliver a standard traumatic impact to rats. Western blot, RT-PCR and ELISA were used to analyze the expression of Nogo-A and IL-1β. Nogo-A antisense, and an irrelevant control oligonucleotide was intracerebroventricularly infused. We also performed H & E staining and luxol fast blue staining to evaluate the neuronal damage and demyelination resulting from TBI and various treatments.
RESULTS:
Based on RT-PCR and western blot analyses, the expression of Nogo-A was found to be significantly upregulated in the hippocampus beginning eight hours after TBI. In addition, TBI caused an apparent elevation in IL-1β levels and severe neuronal damage and demyelination in the tested animals. All of the TBI-associated molecular and cellular consequences could be effectively reversed by treating the animals with the anti-inflammatory drug indomethacin. More importantly, the TBI-associated stimulation in the levels of both Nogo-A and IL-1β could be effectively inhibited by a specific Nogo-A antisense oligonucleotide.
CONCLUSIONS:
Our findings suggest that the suppression of Nogo-A expression appears to be an early response conferred by indomethacin, which then leads to decreases in the levels of IL-1β and TBI-induced neuron damage.
AuthorsPo-Kuan Chao, Kwok-Tung Lu, Ji-Yi Jhu, Yu-Yuan Peter Wo, Tai-Chun Huang, Long-Sun Ro, Yi-Ling Yang
JournalJournal of neuroinflammation (J Neuroinflammation) Vol. 9 Pg. 121 (Jun 07 2012) ISSN: 1742-2094 [Electronic] England
PMID22676811 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-1beta
  • Myelin Proteins
  • Neuroprotective Agents
  • Nogo Proteins
  • Rtn4 protein, rat
  • Indomethacin
Topics
  • Animals
  • Brain Injuries (drug therapy, metabolism, pathology)
  • Hippocampus (drug effects, metabolism)
  • Indomethacin (pharmacology, therapeutic use)
  • Interleukin-1beta (antagonists & inhibitors, metabolism)
  • Male
  • Myelin Proteins (antagonists & inhibitors, biosynthesis, genetics)
  • Neurons (drug effects, metabolism, pathology)
  • Neuroprotective Agents (pharmacology, therapeutic use)
  • Nogo Proteins
  • Rats
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: